Mitochondrial amidoxime reducing component 1

MTARC1
Identifiers
AliasesMTARC1, MOSC1, mitochondrial amidoxime reducing component 1, MARC1
External IDsOMIM: 614126; MGI: 1913362; GeneCards: MTARC1
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

64757

66112

Ensembl

ENSG00000186205

ENSMUSG00000026621

UniProt

Q5VT66

Q9CW42

RefSeq (mRNA)

NM_022746

NM_001081361
NM_001290273

RefSeq (protein)

NP_073583

NP_001277202

Location (UCSC)Chr 1: 220.79 – 220.82 MbChr 1: 184.52 – 184.54 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Mitochondrial amidoxime-reducing component 1 (also known as MOCO sulphurase C-terminal domain containing 1, MOSC1 or MARC1) is a mammalian molybdenum-containing enzyme. It is located in the outer mitochondrial membrane and consists of a N-terminal mitochondrial signal domain facing the inter-membrane space, a transmembrane domain, and a C-terminal catalytic domain facing the cytosol. In humans it is encoded by the MOSC1 gene.

MOCO stands for molybdenum cofactor.

MOSC1 has been reported to reduce amidoximes to amidines.

Genetic variation in MARC1 has been reported to be associated with lower blood cholesterol levels, blood liver enzyme levels, reduced liver fat and protection from cirrhosis suggesting that MARC1 deficiency may protect against liver disease. A genome-wide association study involving subjects from the UK Biobank further established an association of alcoholic-related liver disease.